Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aliskiren Versus Ramipril on Antiproteinuric Effect in Hypertensive, Type 2 Diabetic Patients With Microalbuminuria

NCT01038895 is registered in ClinicalTrials.gov with University of Pavia as lead sponsor.

NCT NCT01038895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01038895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aliskiren Versus Ramipril on Antiproteinuric Effect in Hypertensive, Type 2 Diabetic Patients With Microalbuminuria
Lead sponsor
University of Pavia
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2009
Completion date
June 30, 2011
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, type 2 diabetes